Most Popular
-
1
Dongduk Women’s University halts coeducation talks
-
2
Defense ministry denies special treatment for BTS’ V amid phone use allegations
-
3
OpenAI in talks with Samsung to power AI features, report says
-
4
Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says
-
5
Two jailed for forcing disabled teens into prostitution
-
6
Trump picks ex-N. Korea policy official as his principal deputy national security adviser
-
7
S. Korea not to attend Sado mine memorial: foreign ministry
-
8
South Korean military plans to launch new division for future warfare
-
9
Kia EV9 GT marks world debut at LA Motor Show
-
10
Gold bars and cash bundles; authorities confiscate millions from tax dodgers
Orient Bio reports US$89.9m annual sales, 100m operating profit
By 황유미Published : June 29, 2016 - 16:45
[DISCLOSURE] Orient Bio (002630) reported on June 29 that between April 2015 and March 2016 it posted sales of 105 billion won (US$89.9 million) and 100 million in operating profit. The pharmaceutical company recorded 2.5 billion won net loss for the fiscal year.
